Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7RFS

Structure of SARS-CoV-2 main protease in complex with a covalent inhibitor

Summary for 7RFS
Entry DOI10.2210/pdb7rfs/pdb
Descriptor3C-like proteinase, (1R,2S,5S)-N-{(1E,2S)-1-imino-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide (3 entities in total)
Functional Keywordsprotease sars-cov-2 covalent complex inhibitor, hydrolase-inhibitor complex, hydrolase/inhibitor
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
Total number of polymer chains1
Total formula weight34327.09
Authors
Greasley, S.E.,Ferre, R.A.,Liu, W.,Stewart, A.E. (deposition date: 2021-07-14, release date: 2021-11-10, Last modification date: 2022-01-05)
Primary citationOwen, D.R.,Allerton, C.M.N.,Anderson, A.S.,Aschenbrenner, L.,Avery, M.,Berritt, S.,Boras, B.,Cardin, R.D.,Carlo, A.,Coffman, K.J.,Dantonio, A.,Di, L.,Eng, H.,Ferre, R.,Gajiwala, K.S.,Gibson, S.A.,Greasley, S.E.,Hurst, B.L.,Kadar, E.P.,Kalgutkar, A.S.,Lee, J.C.,Lee, J.,Liu, W.,Mason, S.W.,Noell, S.,Novak, J.J.,Obach, R.S.,Ogilvie, K.,Patel, N.C.,Pettersson, M.,Rai, D.K.,Reese, M.R.,Sammons, M.F.,Sathish, J.G.,Singh, R.S.P.,Steppan, C.M.,Stewart, A.E.,Tuttle, J.B.,Updyke, L.,Verhoest, P.R.,Wei, L.,Yang, Q.,Zhu, Y.
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19.
Science, 374:1586-1593, 2021
Cited by
PubMed: 34726479
DOI: 10.1126/science.abl4784
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.91 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon